Document is current
Any future updates will be listed below
-
Authors
Salbach, Christian
Yildirim, Mustafa
Hund, Hauke
Müller-Hennessen, Matthias
Frey, Norbert
Katus, Hugo Anton
Giannitsis, Evangelos
Milles, Barbara Ruth
-
Funding
Funding for this research was provided by:
Daiichi Sankyo Europe
Bayer
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 15 November 2024
Accepted: 20 February 2025
First Online: 3 March 2025
Declarations
:
: This study was approved by the Ethics Committee of the University of Heidelberg (S-377/2013). Since this study involves no patients and uses data from clinical routine care, a consent to participate declaration was not applicable.
: Not applicable.
: Competing interests MMH received research funding from BRAHMS, Thermo Fisher Scientific and Roche Diagnostics. EG received honoraria for lectures from Roche Diagnostics, AstraZeneca, Bayer, Daiichi-Sankyo, Lilly Eli Deutschland. He serves as a consultant for Roche Diagnostics, BRAHMS Thermo Fisher Scientific, Boehringer Ingelheim and has received research funding from BRAHMS Thermo Fisher Scientific, Roche Diagnostics, Bayer Vital and Daiichi Sankyo. NF has received speaker honoraria from Daiichi Sankyo, Astra Zeneca, Boehringer Ingelheim and Bayer Vital. He serves as a consultant for ZOLL CMS. BRM, received research funding from Daiichi Sankyo. There are no disclosures for HAK, MY, HH and CS.
